Display Settings:

Format

Send to:

Choose Destination

    Mol Biol Cell. 2001 Aug;12(8):2328-40.

    Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions.

    Shav-Tal Y, Cohen M, Lapter S, Dye B, Patton JG, Vandekerckhove J, Zipori D.

    Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.

    The spatial nuclear organization of regulatory proteins often reflects their functional state. PSF, a factor essential for pre-mRNA splicing, is visualized by the B92 mAb as discrete nuclear foci, which disappeared during apoptosis. Because this mode of cell death entails protein degradation, it was considered that PSF, which like other splicing factors is sensitive to proteolysis, might be degraded. Nonetheless, during the apoptotic process, PSF remained intact and was N-terminally hyperphosphorylated on serine and threonine residues. Retarded gel migration profiles suggested differential phosphorylation of the molecule in mitosis vs. apoptosis and under-phosphorylation during blockage of cells at G1/S. Experiments with the use of recombinant GFP-tagged PSF provided evidence that in the course of apoptosis the antigenic epitopes of PSF are masked and that PSF reorganizes into globular nuclear structures. In apoptotic cells, PSF dissociated from PTB and bound new partners, including the U1--70K and SR proteins and therefore may acquire new functions.

    PMID: 11514619 [PubMed - indexed for MEDLINE]

    PMCID: 58597

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Dactinomycin (Cosmegen®)

      Your doctor has ordered the drug dactinomycin to help treat your illness. The drug is given by injection into a vein.